THE-DET-OAK
IncreasedMyT @ ULV
here is the problem, there is where backing your studies backing up your statements with studies, or b not believing anything that doesn't have a study done in the last year with exact parameters can get you ini trouble.
Just because something is 20 years doesn't mean anything has changed. The medical field thought testosterone gave you prostate cancer for 70 years.
Lipschultz has a lot of recent info, and his style of treatment is the most common one your gonna see around here, he is one of the best docs in TRT, and i doubt his opinion has changed much.
if you don't like one of the best TRT docs in the world's word for it, and the countless programs I've witnessed, here is something from AACE in 2006
https://www.aace.com/files/hypo-gonadism.pdf
wat wat
dropping bombs
Just because something is 20 years doesn't mean anything has changed. The medical field thought testosterone gave you prostate cancer for 70 years.
Lipschultz has a lot of recent info, and his style of treatment is the most common one your gonna see around here, he is one of the best docs in TRT, and i doubt his opinion has changed much.
if you don't like one of the best TRT docs in the world's word for it, and the countless programs I've witnessed, here is something from AACE in 2006
Gonadotropin Therapy in Androgen Deficiency
It is known that hCG binds to Leydig cell LH receptors
and stimulates the production of testosterone.
Peripubertal boys with hypogonadotropic hypogonadism
and delayed puberty can be treated with hCG instead of
testosterone to induce pubertal development. The initial
regimen of hCG is usually 1,000 to 2,000 IU administered
intramuscularly two to three times a week (65). The clinical
response is monitored, and testosterone levels are measured
about every 2 to 3 months. Dosage adjustments of
hCG may be needed to determine an optimal schedule.
Increasing doses of hCG may reduce testicular stimulation
by down-regulating the end-organ; thus, a more optimal
result may occur with less frequent or reduced dosing. The
half-life of hCG is long.
The advantages of hCG over testosterone in this setting
include the stimulation of testicular growth, which
may be an important issue for some men. Use of hCG may
also yield greater stability of testosterone levels and fewer
fluctuations in hypogonadal symptoms (66). In addition,
hCG treatment is necessary for stimulating enough intratesticular
testosterone to allow the initiation of spermatogenesis.
The disadvantages of hCG include the need for
more frequent injections and the greater cost.
https://www.aace.com/files/hypo-gonadism.pdf
wat wat
dropping bombs
Last edited: